An algorithm for molecular dissection of tumor progression

被引:0
|
作者
Tian Liu
Wei Zhao
Lili Tian
Rongling Wu
机构
[1] University of Florida,Departments of Statistics
[2] 533 McCarty Hall C University of Florida,Department of Statistics
来源
关键词
Tumor growth; Growth trajectory; Gompertzian curve; Maximum likelihood; QTL;
D O I
暂无
中图分类号
学科分类号
摘要
The volumetric growth of tumor cells as a function of time is most often likely to be a complex trait, controlled by the combined influences of multiple genes and environmental influences. Genetic mapping has proven to be a powerful tool for detecting and identifying specific genes affecting complex traits, i.e., quantitative trait loci (QTL), based on polymorphic markers. In this article, we present a novel statistical model for genetic mapping of QTL governing tumor growth trajectories in humans. In principle, this model is a combination of functional mapping proposed to map function-valued traits and linkage disequilibrium mapping designed to provide high resolution mapping of QTL by making use of recombination events created at a historic time. We implement an EM-simplex hybrid algorithm for parameter estimation, in which a closed-form solution for the EM algorithm is derived to estimate the population genetic parameters of QTL including the allele frequencies and the coefficient of linkage disequilibrium, and the simplex algorithm incorporated to estimate the curve parameters describing the dynamic changes of cancer cells for different QTL genotypes. Extensive simulations are performed to investigate the statistical properties of our model. Through a number of hypothesis tests, our model allows for cutting-edge studies aimed to decipher the genetic mechanisms underlying cancer growth, development and differentiation. The implications of our model in gene therapy for cancer research are discussed.
引用
收藏
页码:336 / 354
页数:18
相关论文
共 50 条
  • [41] Molecular mechanism of ferulic acid and its derivatives in tumor progression
    Xingxun Bao
    Wei Li
    Ruixue Jia
    Dandan Meng
    Hairong Zhang
    Lei Xia
    Pharmacological Reports, 2023, 75 : 891 - 906
  • [42] Molecular mechanisms of microRNA-216a during tumor progression
    Amir Abbas Hamidi
    Negin Taghehchian
    Amir Sadra Zangouei
    Iman Akhlaghipour
    Amirhosein Maharati
    Zahra Basirat
    Meysam Moghbeli
    Cancer Cell International, 23
  • [43] Role of heparanase in tumor progression: Molecular aspects and therapeutic options
    Masola, Valentina
    Zaza, Gianluigi
    Gambaro, Giovanni
    Franchi, Marco
    Onisto, Maurizio
    SEMINARS IN CANCER BIOLOGY, 2020, 62 : 86 - 98
  • [44] Molecular functions of the tumor progression protein CD44
    Ponta, H
    Sleeman, J
    Sherman, L
    Moll, J
    Herrlich, P
    EUROPEAN JOURNAL OF CANCER, 1997, 33 : 106 - 106
  • [45] Endometrial carcinoma: molecular alterations involved in tumor development and progression
    Yeramian, A.
    Moreno-Bueno, G.
    Dolcet, X.
    Catasus, L.
    Abal, M.
    Colas, E.
    Reventos, J.
    Palacios, J.
    Prat, J.
    Matias-Guiu, X.
    ONCOGENE, 2013, 32 (04) : 403 - 413
  • [46] Endometrial carcinoma:: Molecular alterations related with tumor progression.
    Prat, J
    Catasús, L
    Matias-Guiu, X
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S3 - S3
  • [47] Endometrial carcinoma: molecular alterations involved in tumor development and progression
    A Yeramian
    G Moreno-Bueno
    X Dolcet
    L Catasus
    M Abal
    E Colas
    J Reventos
    J Palacios
    J Prat
    X Matias-Guiu
    Oncogene, 2013, 32 : 403 - 413
  • [48] Hypoxia-regulated microRNAs: the molecular drivers of tumor progression
    Sawai, Sakunie
    Wong, Pooi-Fong
    Ramasamy, Thamil Selvee
    CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2022, 57 (04) : 351 - 376
  • [49] Molecular mechanism of palmitic acid and its derivatives in tumor progression
    Wang, Xitan
    Zhang, Chaonan
    Bao, Na
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [50] Towards a definition of the molecular processes associated with tumor progression.
    Bozic, C
    Pillot-Brochet, C
    Malinge, S
    Wagner, S
    Gautier, A
    Gadal, F
    Crepin, M
    Iris, F
    Buffat, L
    Treich, I
    CLINICAL CANCER RESEARCH, 1999, 5 : 3778S - 3779S